Key Drivers
- Strong cash conversion
- Thin latest margins
- Elevated leverage
AIAI Summary
USPH should be viewed less as a defensive healthcare compounder and more as an execution story where solid revenue growth is being offset by margin compression and weak quarterly cash conversion, so the key takeaway is that the stock likely stays under pressure until management proves operating leverage can recover faster than labor and reimbursement costs.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong cash conversion
- •Thin latest margins
- •Elevated leverage
USPH remains a cash-generative, modestly profitable business, but weaker latest-quarter margins, rising leverage, heavy intangibles, and an uncovered dividend temper its appeal.
Price Behavior
Key Price Behavior Insights:
- •Support defended
- •Resistance overhead
- •Weak rebound
USPH's last month chart shows a sharp breakdown and volatile selloff, with $59-$60 acting as near-term support but the stock remaining weak below $65-$66 and the $71-$74 resistance band. ക
Sharp drop from $73.61 on 2026-05-06 to $59.00 on 2026-05-07 signaled sudden seller control and volatility
Sentiment & News
Key News Insights:
- •Revenue growth
- •EPS miss
- •Guidance steady
USPH delivered record Q1 revenue and reaffirmed full-year guidance, but EPS missed estimates, indicating strong sales growth offset by softer profitability.
The results are modestly negative for USPH as investors may prioritize margin execution and earnings quality despite continued top-line momentum
Similar Companies in Healthcare
Other companies in the same sector with AI ratings